19 April 2024
Vaccines | 2023 Notable Papers in the Section “Cancer Vaccines and Immunotherapy”

1. “Myeloid-Derived Suppressor Cells in Cancer and COVID-19 as Associated with Oxidative Stress”
by Celia María Curieses Andrés, José Manuel Pérez de la Lastra, Celia Andrés Juan, Francisco J. Plou and Eduardo Pérez-Lebeña
Vaccines 2023, 11(2), 218; https://doi.org/10.3390/vaccines11020218
Full text available online: https://www.mdpi.com/2076-393X/11/2/218

2. “Evolution and Progress of mRNA Vaccines in the Treatment of Melanoma: Future Prospects”
by Dimitrios Bafaloukos, Ioanna Gazouli, Christos Koutserimpas and George Samonis
Vaccines 2023, 11(3), 636; https://doi.org/10.3390/vaccines11030636
Full text available online: https://www.mdpi.com/2076-393X/11/3/636

3. “Phosphatidylserine-Exposing Annexin A1-Positive Extracellular Vesicles: Potential Cancer Biomarkers”
by Gloria I. Perez, Matthew P. Bernard, Daniel Vocelle, Ahmed A. Zarea, Najla A. Saleh, Matthew A. Gagea, Doug Schneider, Maxine Bauzon, Terry Hermiston and Masamitsu Kanada
Vaccines 2023, 11(3), 639; https://doi.org/10.3390/vaccines11030639
Full text available online: https://www.mdpi.com/2076-393X/11/3/639

4. “Survivin (BIRC5) Peptide Vaccine in the 4T1 Murine Mammary Tumor Model: A Potential Neoadjuvant T Cell Immunotherapy for Triple Negative Breast Cancer: A Preliminary Study”
by Scott R. Burkholz, Charles V. Herst, Richard T. Carback, Paul E. Harris and Reid M. Rubsamen
Vaccines 2023, 11(3), 644; https://doi.org/10.3390/vaccines11030644
Full text available online: https://www.mdpi.com/2076-393X/11/3/644

5. “The Impact of COVID-19 on Pediatric Malignancy Diagnosis and Treatment: Never the Same but Lessons Learned”
by Ghadir K. Katato, Prasiksha Sitaula, Avanti Gupte and Eman T. Al-Antary
Vaccines 2023, 11(3), 667; https://doi.org/10.3390/vaccines11030667
Full text available online: https://www.mdpi.com/2076-393X/11/3/667

6. “Anti-HERV-K Drugs and Vaccines, Possible Therapies against Tumors”
by Sepideh Hosseiniporgham and Leonardo Antonio Sechi
Vaccines 2023, 11(4), 751; https://doi.org/10.3390/vaccines11040751
Full text available online: https://www.mdpi.com/2076-393X/11/4/751

7. “T Cell Based Immunotherapy for Cancer: Approaches and Strategies”
by Muzamil Y. Want, Zeenat Bashir and Rauf A. Najar
Vaccines 2023, 11(4), 835; https://doi.org/10.3390/vaccines11040835
Full text available online: https://www.mdpi.com/2076-393X/11/4/835

8. “Engineered Phage-Based Cancer Vaccines: Current Advances and Future Directions”
by Murali Ragothaman and So Young Yoo
Vaccines 2023, 11(5), 919; https://doi.org/10.3390/vaccines11050919
Full text available online: https://www.mdpi.com/2076-393X/11/5/919

9. “A Comprehensive Review on Cancer Vaccines and Vaccine Strategies in Hepatocellular Carcinoma”
by Alireza Tojjari, Ahmed Saeed, Meghana Singh, Ludimila Cavalcante, Ibrahim Halil Sahin and Anwaar Saeed
Vaccines 2023, 11(8), 1357; https://doi.org/10.3390/vaccines11081357
Full text available online: https://www.mdpi.com/2076-393X/11/8/1357

10. “Cemiplimab in Ultra-Octogenarian Patients with Cutaneous Squamous Cell Carcinoma: The Real-Life Experience of a Tertiary Referral Center”
by Nerina Denaro, Emanuela Passoni, Alice Indini, Gianluca Nazzaro, Giada Anna Beltramini, Valentina Benzecry, Giuseppe Colombo, Carolina Cauchi, Cinzia Solinas, Mario Scartozzi et al.
Vaccines 2023, 11(9), 1500; https://doi.org/10.3390/vaccines11091500
Full text available online: https://www.mdpi.com/2076-393X/11/9/1500

Back to TopTop